AMPH  valuation analysis

Basics
Name: Amphastar Pharmaceuticals, Inc
Description: Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Mar 15, 2021
Market cap: $826.42M (1293rd)
Sales(TTM): $349.85M (1277th)
Earnings(TTM): $1.10M (1050th)

Value
FFER: 0.72 (why)
Actual price: $17.40
FFEThis is Amphastar Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $24.96
Quantile: AMPH is cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Amphastar Pharmaceuticals, Inc's operating income increased from -$39,000 to $10.95M in the last year.
Earnings / MarketCap
Amphastar Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Amphastar Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Amphastar Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Amphastar Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry